Dexrazoxane (Alvogen Inc.)


Welcome to the PulseAid listing for the Dexrazoxane drug offered from Alvogen Inc.. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alvogen Inc.
NON-PROPRIETARY NAME: Dexrazoxane for Injection
SUBSTANCE NAME: DEXRAZOXANE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytoprotective Agent [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-09-01
END MARKETING DATE: 0000-00-00


Dexrazoxane HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDexrazoxane from Alvogen Inc.
LABELER NAME: Alvogen Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/50mL)
START MARKETING DATE: 2017-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 47781-578_6d0fbbe0-a755-ec98-0b79-8b3348ed0a5d
PRODUCT NDC: 47781-578
APPLICATION NUMBER: ANDA207321

Other DEXRAZOXANE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alvogen Inc.Dexrazoxane
Breckenridge Pharmaceutical, Inc.Dexrazoxane
Clinigen Healthcare LtdCardioxane
Cumberland Pharmaceuticals Inc.Totect
Gland Pharma LimitedDexrazoxane
Pharmacia and Upjohn Company LLCZinecard
ThyMoorgan GmbH Pharmazir & Co. K.GDexrazoxane
West-Ward Pharmaceuticals CorpDexrazoxane